Status:
COMPLETED
Exacerbating Factors in Inflammatory Bowel Disease
Lead Sponsor:
Dallas VA Medical Center
Collaborating Sponsors:
Centocor Ortho Biotech Services, L.L.C.
Conditions:
Ulcerative Colitis
Crohn's Disease
Eligibility:
All Genders
18+ years
Brief Summary
Cross-sectional study of potential triggers for flares of Crohn's disease or ulcerative colitis.
Detailed Description
Detailed questionnaires with patient in regards to potential triggers for flares of IBD. Includes both patients with flares and those in remission as a control group.
Eligibility Criteria
Inclusion
- History of verified Crohn's disease or ulcerative colitis
Exclusion
- unwilling to participate
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT01405105
Start Date
August 1 2009
End Date
June 1 2012
Last Update
February 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dallas VA Medical Center
Dallas, Texas, United States, 75216